Martine Rothblatt
2020
In 2020, Martine Rothblatt earned a total compensation of $4.8M as Chairperson and Chief Executive Officer at United Therapeutics, a 89% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,575,757 |
|---|---|
| Non-Equity Incentive Plan | $1,873,080 |
| Salary | $1,352,435 |
| Other | $10,400 |
| Total | $4,811,672 |
Rothblatt received $1.9M in non-equity incentive plan, accounting for 39% of the total pay in 2020.
Rothblatt also received $1.6M of change in pension value and nonqualified deferred compensation earnings, $1.4M in salary and $10.4K in other compensation.
Rankings
In 2020, Martine Rothblatt's compensation ranked 2,313th out of 13,090 executives tracked by ExecPay. In other words, Rothblatt earned more than 82.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,313 out of 13,090 | 82nd |
Division Manufacturing | 888 out of 5,617 | 84th |
Major group Chemicals And Allied Products | 318 out of 2,248 | 86th |
Industry group Drugs | 269 out of 1,948 | 86th |
Industry Pharmaceutical Preparations | 193 out of 1,453 | 87th |
Source: SEC filing on April 29, 2022.
Rothblatt's colleagues
We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2020.